ZA869399B - Thrombosis treatment with fibrinolytics and prostacyclins - Google Patents

Thrombosis treatment with fibrinolytics and prostacyclins

Info

Publication number
ZA869399B
ZA869399B ZA869399A ZA869399A ZA869399B ZA 869399 B ZA869399 B ZA 869399B ZA 869399 A ZA869399 A ZA 869399A ZA 869399 A ZA869399 A ZA 869399A ZA 869399 B ZA869399 B ZA 869399B
Authority
ZA
South Africa
Prior art keywords
prostacyclins
fibrinolytics
thrombosis treatment
thrombosis
treatment
Prior art date
Application number
ZA869399A
Other languages
English (en)
Inventor
Berthold Baldus
Bernhard Maass
Bernd Mueller
Werner Witt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA869399B publication Critical patent/ZA869399B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA869399A 1985-12-13 1986-12-12 Thrombosis treatment with fibrinolytics and prostacyclins ZA869399B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853544663 DE3544663A1 (de) 1985-12-13 1985-12-13 Thrombosebehandlung mit fibrinolytika und prostacyclinen

Publications (1)

Publication Number Publication Date
ZA869399B true ZA869399B (en) 1987-08-26

Family

ID=6288681

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA869399A ZA869399B (en) 1985-12-13 1986-12-12 Thrombosis treatment with fibrinolytics and prostacyclins

Country Status (14)

Country Link
US (1) US5316766A (xx)
EP (1) EP0228988B1 (xx)
JP (1) JPH0764748B2 (xx)
AT (1) ATE104151T1 (xx)
AU (1) AU610058B2 (xx)
CA (1) CA1283357C (xx)
DE (2) DE3544663A1 (xx)
DK (1) DK419487A (xx)
ES (1) ES2051695T3 (xx)
HU (1) HU206183B (xx)
IE (1) IE64462B1 (xx)
IL (1) IL80900A (xx)
WO (1) WO1987003488A1 (xx)
ZA (1) ZA869399B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001355A (en) * 1982-12-14 1999-12-14 Dowdle; Eugene Bernard Davey Pro-tPA for the treatment of thrombosis, embolism and related conditions
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
NZ221977A (en) * 1986-10-09 1991-03-26 Smithkline Beckman Corp Thrombolytic composition comprising a plasminogen activator (tpa, uk or sk) and a thromboxane synthase inhibitor; kits thereof and process for preparation thereof
EP0299376A3 (en) * 1987-07-13 1990-01-24 William Elson Shell Prostanoid compositions and methods for reducing blood vessel dysfunction
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) * 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) * 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
DE69435137D1 (de) * 1993-05-13 2008-10-16 Poniard Pharmaceuticals Inc Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
JPH11510479A (ja) 1995-06-07 1999-09-14 ネオルックス コーポレイション タモキシフェン類似体による心臓血管疾病の予防及び治療

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5978179A (ja) * 1982-10-26 1984-05-04 Sankyo Co Ltd エポキシカルバサイクリン誘導体およびその製造法
DE3686684T2 (de) * 1985-03-06 1993-01-28 Survival Technology Mittel zur absorptionsverbesserung von proteinen.
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination

Also Published As

Publication number Publication date
HUT44936A (en) 1988-05-30
HU206183B (en) 1992-09-28
DE3689789D1 (de) 1994-05-19
WO1987003488A1 (en) 1987-06-18
AU610058B2 (en) 1991-05-16
EP0228988B1 (de) 1994-04-13
DK419487D0 (da) 1987-08-12
ES2051695T3 (es) 1994-07-01
EP0228988A1 (de) 1987-07-15
IE64462B1 (en) 1995-08-09
ATE104151T1 (de) 1994-04-15
JPS63501951A (ja) 1988-08-04
DK419487A (da) 1987-08-12
DE3544663A1 (de) 1987-06-19
CA1283357C (en) 1991-04-23
US5316766A (en) 1994-05-31
AU6772387A (en) 1987-06-30
IL80900A0 (en) 1987-03-31
IE863249L (en) 1987-06-13
JPH0764748B2 (ja) 1995-07-12
IL80900A (en) 1991-11-21

Similar Documents

Publication Publication Date Title
ZA869399B (en) Thrombosis treatment with fibrinolytics and prostacyclins
GB8822147D0 (en) Pharmaceutically active combination
GB8605506D0 (en) Desulfurizing & denigrating agents
GR3003991T3 (xx)
AR245000A1 (es) Un metodo para preparar composiciones fibrinoliticas mejoradas.
GR3006630T3 (xx)
PT83575A (en) Methyleneamino quinuclidines
GR81852B (xx)
GR78135B (xx)
DE3171558D1 (en) Powdered elastomers and process thereof
GB8406696D0 (en) Amplifier with bipolar transistors
ZA857721B (en) Process for treatment of rheumatic diseases
ZA886401B (en) Modified plasminogen activators
EP0270782A3 (en) Therapeutic agents for the prophylaxis of tumour metastasis
PH22416A (en) Method of improving the resorption of injected antibacterially active substances or combination
ZA862429B (en) O-sulfated beta-lactam hydroxamic acids
DE3664826D1 (en) Process for the improvement of ferromagnetic chromium dioxide
EP0612750A3 (en) Cephalosporinderivatives.
EP0236510A4 (en) PROSTACYCLINES AND MEDICINES CONTAINING THEM.
GB8710618D0 (en) Bipolar transistors
AU90259S (en) Bottle
IE872232L (en) Formulation of alpha-interferon.
CS85488A1 (en) Carburizing agents
AU99746S (en) A bottle
HUT47879A (en) Connection arrangement for improving the static and dynamic accuracy of robots of multiple degree of freedom